Jardine Matheson account plan
Diversified Asian business portfolio
At a glance
Jardine Matheson is an Asia-focused investment company founded in 1832, with US$34,217m revenue and US$1,681m underlying net profit in 2025.
Jardine Matheson Holdings (Jardines) is a diversified, Asia-focused investment company founded in China in 1832, holding controlling stakes in businesses across Asia Pacific: Astra in Indonesia, Hongkong Land, DFI Retail, Jardine Pacific, Jardine Cycle & Carriage and Mandarin Oriental. In 2025 it repositioned "from an owner-operator to an investment company". FY2025 revenue was US$34,217m (-4%) and underlying net profit US$1,681m (+11%); the portfolio counts 384,000 FTEs according to the CEO. It is incorporated in Bermuda, with a primary listing in London and secondary listings in Bermuda and Singapore, and the Keswick family act as long-term stewards.
Business units
Astra
46% of FY2025 underlying net profit (US$787m)Indonesia-listed conglomerate spanning automotive, financial services, heavy equipment and mining contracting, infrastructure and healthcare; segment revenue US$19,608m in 2025. Its H1 2026 contribution fell 8% to US$358m on a weak rupiah, a mining slowdown and the Martabe gold mine stoppage. Led by President Director Rudy Chen.
Hongkong Land
14% of FY2025 underlying net profit (US$245m)Property investment, development and management group focused on ultra-premium integrated commercial property in Asia's gateway cities, with US$50bn of AUM. Its H1 2026 contribution rose 14% to US$140m. Led by Chief Executive Michael Smith.
DFI Retail Group
12% of FY2025 underlying net profit (US$209m)Asian retailer with some 7,600 outlets in 12 markets under banners such as Mannings, Guardian, 7-Eleven, Wellcome and IKEA. It raised 2026 guidance to US$285-305m underlying net profit after nearly US$1 billion of divestments.
Jardine Pacific
11% of FY2025 underlying net profit (US$191m)Wholly owned holding company for Hong Kong unlisted businesses; over 94% of its profit comes from Engineering and Infrastructure (Gammon, Jardine Schindler, JEC, HACTL), plus motor retail and restaurants. Led by Chief Executive Elton Chan.
Jardine Cycle & Carriage (excluding Astra)
9% of FY2025 underlying net profit (US$155m)Listed holding company for Astra, Vietnam holdings (THACO, REE) and Southeast Asian auto retail; to be renamed Jardine Matheson Southeast Asia Limited. Led by CEO Freddy Lee.
Mandarin Oriental
4% of FY2025 underlying net profit (US$68m)Luxury hotel, resort and residences owner and operator with 45 hotels in 28 countries and territories, privatised in January 2026. Led by Group Chief Executive Laurent Kleitman.
Zhongsheng
Chinese mainland car-dealer interest that contributed US$60m in 2025; a US$732m impairment was taken and from 2026 it is accounted for as an investment.
Strategic priorities
- 2030 TSR and dividend commitments
- Set at the first Investor Day in June 2026: 5Y TSR of at least 9% p.a., dividend growth of at least 5% a year, at least US$4bn of capital recycled and at least US$200m of underlying net profit from new growth pillars by 2030.
- Build new pillars and diversify
- The CEO says the group has too much exposure to Astra; new investments must be controlled market leaders with a path to a hundred million dollars in PATAM, with an 11% minimum return.
- Active capital recycling
- US$4.8bn was recycled in 2025 and US$1.5bn in H1 2026, exiting below-hurdle and non-controlled holdings such as Vinamilk, Zhongsheng and Toyota shares.
- Lean holding company
- JMH headcount fell around 47% compared with 2024, and the CEO said upgrading talent would be an absolute priority in 2026.
- Engineering platform
- Jardine Engineering & Infrastructure (JEI) is to be built into a regional platform through organic growth, targeted M&A and synergies, targeting double earnings by 2030.
Latest results
In H1 2026 underlying net profit was US$735m, up 9% adjusted for disposals and the Zhongsheng reclassification, and reported net profit US$542m (+3%) on revenue of US$15,924m (-7%). JMH parent free cash flow rose 21% to US$709m and parent net cash reached US$379m. Astra's contribution fell 8% while Hongkong Land rose 14% and DFI 11%. Full-year profit guidance is unchanged, in line with 2025 after adjustments, and the 2026 dividend is expected to be at least US$2.47 per share.
Investments and deals
- I-MED Radiology Network
- US$2.4bn acquisition of Australia's largest radiology business, announced in May 2026 and expected to close in Q4 2026, bought at 11.5x EV/EBITDA according to the CEO.
- Mandarin Oriental privatisation
- JMH acquired the remaining 11.96% for US$925m, completing the privatisation in January 2026.
- Share buybacks
- After a US$250m programme announced in November 2025, a follow-on US$500m buyback runs to end-2027.
- Portfolio capex
- Capital expenditure and investments were US$2,801m in 2025, including US$976m at Astra and US$113m at DFI for store refurbishment.
- Landmark transformation
- Hongkong Land's US$1bn Tomorrow Central transformation of the Landmark, with rental income expected to rise by more than 20% afterwards.
Challenges and risks
- Concentration on Astra and Indonesia
- Astra made 46% of 2025 underlying net profit, and Indonesia faces capital outflows, a weak rupiah and a mining slowdown.
- Weak consumption
- The Chairman flagged soft mass-market consumption in Hong Kong, China's real estate market weighing on sentiment, and weak middle-class consumption in Indonesia hurting four-wheeler sales.
- Shareholder returns
- The 5-year TSR was 4.4% p.a. at H1 2026, against a 2030 target of at least 9% p.a.
- Hong Kong office market
- Prime Central office rents fell close to 44% from the mid-2019 peak before recovering, and lower occupancy and the Landmark renovation cut HKL's investment profit in 2025.
- Technology and cybersecurity
- The revised principal risks include technology and cybersecurity, including generative AI, alongside climate and geopolitical risk.
What leadership says
“Our focus as we enter H2 is to continue driving TSR, improving cash flow across our portfolio, portfolio simplification and importantly, integrating I-MED Radiology Network into our portfolio.”
“Nine percent at least for total shareholder return. Eleven percent minimum for new investments. Seven percent hurdle.”
“Upgrading our talent will be an absolute priority in 2026.”
“We're in no rush to deploy our capital.”
Where a supplier can help
- Integrating I-MED and future pillars
- Integrating I-MED and acquiring further new pillars calls for M&A advisory, integration, finance and reporting support.
- Lean holding-company tooling
- A head office cut by around 47% and an absolute priority on talent favour suppliers of executive search, shared finance systems and automation.
- Engineering platform build-out
- Building JEI into a regional platform that doubles earnings by 2030 opens room for construction technology, equipment and integration partners across Gammon, Schindler, JEC and HACTL.
- Property and retail upgrades
- The Landmark transformation and DFI store refurbishment create demand for fit-out, retail technology and building systems suppliers.
- Cybersecurity and AI risk
- Technology and cybersecurity, including generative AI, are principal risks across a portfolio of many operating companies, a fit for security and governance tools.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Jardine Matheson?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Jardine Matheson Annual Report 2025
- Jardine Matheson (Jardines) is a diversified, Asia-focused investment company founded in China in 1832, with a primary listing in London and a secondary listing in Singapore; in 2025 it moved "from an owner-operator to an investment company".
- FY2025: revenue US$34,217m (-4%); underlying net profit US$1,681m (+11%); underlying EPS US$5.72 (+9%); reported net profit US$1,109m vs a US$468m loss in 2024; full-year dividend US$2.35 (+4%).
- Astra (Indonesia) is the largest contributor: US$787m, 46% of underlying net profit by business; Hongkong Land 14% (US$245m), DFI Retail 12% (US$209m), Jardine Pacific 11% (US$191m), JC&C excl. Astra 9% (US$155m), Mandarin Oriental 4% (US$68m).
- Capital recycling of US$4.8bn across the Group in 2025 (US$8.6bn over five years); US$2.8bn re-invested as capex; JMH parent balance sheet back to net cash (US$41m) and JMH parent free cash flow up 7% to US$933m.
- 5-year TSR recovered to 8.8% p.a. (from -0.6%); it is the principal KPI, with TSR-linked long-term incentives at HKL, DFI and Mandarin Oriental and coming at JMH and Astra in 2026.
- Lincoln Pan (ex-PAG) became CEO on 1 December 2025, succeeding John Witt; Ben Keswick is Executive Chairman, Graham Baker CFO.
- Mandarin Oriental privatised in January 2026; disposals included Yonghui, Robinsons Retail, DFI's Singapore Food business, MCL Land and 13 floors of One Causeway Bay; a US$732m impairment was taken on Zhongsheng.
- 2026 outlook: earnings broadly in line with 2025 adjusted for disposals and Zhongsheng's reclassification (about US¢39 of 2025 EPS); full-year dividend of at least US$2.45 per share.
- Jardine Matheson Half-Year Results 2026 (six months ended 30 June 2026)
- H1 2026 (to 30 June): underlying net profit US$735m, up 9% adjusted for disposals and Zhongsheng's reclassification; reported net profit US$542m (+3%); revenue US$15,924m (-7%).
- JMH parent free cash flow up 21% to US$709m; parent net cash US$379m; interim dividend up 8% to US$0.65; full-year dividend guidance raised to at least US$2.47 per share.
- First Investor Day (June 2026) set 2030 commitments: 5Y TSR of at least 9% p.a., dividend growth of at least 5% p.a., at least US$4bn capital recycling, and at least US$200m underlying net profit from new pillars.
- US$2.4bn acquisition of I-MED Radiology Network (Australia), expected to close in Q4 2026; new follow-on US$500m share buyback running to end-2027.
- US$1.5bn capital recycled and US$3.2bn invested or committed in H1; JMH headcount down about 47% versus 2024.
- Astra contribution fell 8% to US$358m (weak rupiah, mining slowdown, Martabe gold mine stoppage); HKL +14% to US$140m; DFI +11% to US$90m; Jardine Pacific US$102m (+US$35m).
- New Jardine Engineering & Infrastructure (JEI) platform aims to double earnings by 2030; JC&C to be renamed "Jardine Matheson Southeast Asia Limited".
- Jardine Matheson Investor Day 2026: CEO address by Lincoln Pan
- Lincoln Pan's CEO address at Jardines' first Investor Day (16 June 2026), framed as "a progress update. It's not a strategy unveil."
- Jardines must evolve "a one point seven billion dollar company" (in underlying profit) while respecting 194 years of history and 384,000 FTEs; he sees his primary role as managing risk, not doing deals.
- Says capital allocation must change: "we have too much exposure in single asset in Astra"; diversification is "an absolute criticality".
- Capital allocation principles: at least 9% TSR for the portfolio, 11% minimum for new investments, a 7% hurdle; principally control investing.
- New investments must be market leaders, scalable, cash generative, controlled, growth accretive and diversifying, with a path to US$100m in PATAM; no single data centres, non-controlled stakes, private funds or deals that conflict with portfolio companies.
- I-MED: the number one diagnostic player in Australia, bought at 11.5x EV/EBITDA, underwriting to a mid-teens IRR, with financing costs cut by close to 75% on joining.
- Holding company was "bloated"; a capital allocation committee with family members Ben and Adam Keswick now debates deals.
- Has invested more than US$20m of his own money in Jardines; LTIP pays 100% at 10% absolute TSR and needs about US$300m of new-business profit by 2030.
- Jardine Matheson Investor Day 2026: Hongkong Land presentation by Michael Smith
- Michael Smith, Chief Executive of Hongkong Land, at the Jardine Matheson Investor Day (16 June 2026), on HKL's Strategic Vision 2035, launched late 2024.
- HKL refocuses on ultra-premium integrated commercial property in Asia's gateway cities; serves over 2,500 occupiers; AUM reached US$50bn after the Singapore private fund was set up.
- US$3.6bn net proceeds recycled to date; gearing down to around 11%; net debt US$3.5bn at end-March; no more investment in build-to-sell.
- Hong Kong prime Central office rents fell close to 44% from a mid-2019 peak and have grown close to 10% since September 2025; new supply before 2030 is under 2% of stock.
- Landmark: "Tomorrow Central" US$1bn transformation; rental income expected to grow by more than 20% post-transformation; top 100 customers spent HK$1.2bn in 2025.
- SCPREF (with APG and Qatar Investment Authority) to grow from S$8bn to at least S$15bn of AUM within five years; Westbund Central in Shanghai completes by 2029.
- Capital allocation: self-funding, investment-grade rating, up to 20% of recycled proceeds to buybacks; DPS target of 44 US cents by 2035 (now 25); discount to NAV narrowed from close to 80% to 45-50%.
Questions about Jardine Matheson
What does Jardine Matheson do?
Jardine Matheson is a diversified, Asia-focused investment company that holds controlling stakes in Astra, Hongkong Land, DFI Retail, Jardine Pacific, Jardine Cycle & Carriage and Mandarin Oriental.
What is Jardine Matheson's revenue?
FY2025 revenue was US$34,217m (-4%) with underlying net profit of US$1,681m (+11%); H1 2026 revenue was US$15,924m.
What is Jardine Matheson's strategy?
It is moving from owner-operator to investment company, targeting a 5Y TSR of at least 9% p.a. by 2030, active capital recycling and new controlled growth pillars such as I-MED.
Who leads Jardine Matheson?
Lincoln Pan has been CEO since 1 December 2025, Ben Keswick is Executive Chairman and Graham Baker is CFO.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)